X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (182) 182
Publication (22) 22
Book Review (17) 17
Conference Proceeding (8) 8
Book / eBook (3) 3
Dissertation (3) 3
Newspaper Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (111) 111
humans (107) 107
hematology (106) 106
transplantation (105) 105
adult (78) 78
female (73) 73
male (73) 73
middle aged (73) 73
immunology (64) 64
hematology, oncology and palliative medicine (52) 52
hematopoietic stem cells (48) 48
adolescent (47) 47
aged (44) 44
transplantation, homologous (39) 39
article (38) 38
hematopoietic stem cell transplantation - methods (37) 37
treatment outcome (36) 36
bone marrow (34) 34
bone-marrow-transplantation (34) 34
stem cells (34) 34
retrospective studies (31) 31
child (26) 26
analysis (25) 25
disease-free survival (25) 25
transplantation conditioning - methods (25) 25
transplantation, autologous (25) 25
young adult (25) 25
survival analysis (24) 24
abridged index medicus (23) 23
hematopoietic stem cell transplantation - adverse effects (23) 23
cancer (22) 22
stem-cell transplantation (22) 22
chemotherapy (21) 21
child, preschool (21) 21
hematopoietic stem cell transplantation (21) 21
hemic and lymphatic diseases (21) 21
leukemia (21) 21
survival rate (21) 21
mortality (19) 19
survival (19) 19
recurrence (18) 18
surgical procedures, operative (17) 17
therapy (17) 17
versus-host-disease (17) 17
oncology (16) 16
unrelated donors (16) 16
bone marrow transplantation (15) 15
cyclophosphamide (15) 15
acute myeloid-leukemia (14) 14
allogeneic transplantation (14) 14
transplantation conditioning (14) 14
blood (13) 13
care and treatment (13) 13
hematopoietic cell transplantation (13) 13
hematopoietic stem cell transplantation - mortality (13) 13
infant (13) 13
medical research (13) 13
risk factors (13) 13
siblings (13) 13
lymphomas (12) 12
transplants & implants (12) 12
follow-up studies (11) 11
histocompatibility testing (11) 11
medicine, experimental (11) 11
research (11) 11
whole-body irradiation (11) 11
allogeneic (10) 10
antineoplastic combined chemotherapy protocols - therapeutic use (10) 10
clinical trials (10) 10
graft vs host disease - etiology (10) 10
prognosis (10) 10
tissue donors (10) 10
acute disease (9) 9
allogeneic hematopoietic cell transplantation (9) 9
busulfan (9) 9
graft vs host disease - mortality (9) 9
graft vs host disease - prevention & control (9) 9
high-dose chemotherapy (9) 9
myeloablative agonists - therapeutic use (9) 9
prospective studies (9) 9
registries (9) 9
stem cell transplantation (9) 9
acute myelogenous leukemia (8) 8
bone marrow transplantation - adverse effects (8) 8
busulfan - administration & dosage (8) 8
children (8) 8
colony-stimulating factor (8) 8
combined modality therapy (8) 8
european group (8) 8
health aspects (8) 8
hematologic malignancies (8) 8
hematologic neoplasms - therapy (8) 8
immunosuppressive agents - therapeutic use (8) 8
lymphoma (8) 8
medical colleges (8) 8
medicine, general & internal (8) 8
non-hodgkins-lymphoma (8) 8
oncology, experimental (8) 8
proportional hazards models (8) 8
relapse (8) 8
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2016, Volume 388, Issue 10044, pp. 576 - 585
Journal Article
Nature, ISSN 0028-0836, 11/2015, Volume 527, Issue 7579, pp. 459 - 465
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2012, Volume 367, Issue 16, pp. 1487 - 1496
In this study of unrelated-donor transplantation for hematologic cancers, survival was similar with bone marrow and peripheral-blood stem-cell grafts. However,... 
PROGENITOR CELLS | ALLOGENEIC TRANSPLANTATION | MEDICINE, GENERAL & INTERNAL | COLONY-STIMULATING FACTOR | TERM-FOLLOW-UP | RANDOMIZED-TRIAL | MALIGNANCIES | LEUKEMIA | RECIPIENTS | VERSUS-HOST-DISEASE | CHRONIC GRAFT | Recurrence | Graft vs Host Disease - epidemiology | Peripheral Blood Stem Cell Transplantation - adverse effects | Histocompatibility Testing | Humans | Bone Marrow Diseases - mortality | Kaplan-Meier Estimate | Proportional Hazards Models | Leukemia - therapy | Peripheral Blood Stem Cell Transplantation - mortality | Male | Survival Rate | Cause of Death | Graft Rejection - epidemiology | Bone Marrow Transplantation - mortality | Bone Marrow Diseases - therapy | Intention to Treat Analysis | Bone Marrow Transplantation - adverse effects | Adult | Female | Unrelated Donors | Leukemia - mortality | Patient outcomes | Stem cells | Causes of | Bone marrow | Graft versus host reaction | Transplantation | Diagnosis | Comparative analysis | Graft-versus-host reaction | Cell survival | Transplants & implants | Risk groups | Syngeneic grafts | Mortality | Clinical trials | Bone marrow transplantation | Stem cell transplantation | Cardiovascular disease | Genetic diversity | Hematopoietic stem cells | Risk factors | Quality of life | Rejection | Grafts | Motivation | Peripheral blood | Histocompatibility antigen HLA | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2013, Volume 31, Issue 19, pp. 2437 - 2449
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2018, Volume 378, Issue 1, pp. 35 - 47
Scleroderma is a life-threatening autoimmune disease in need of more effective treatment. A randomized trial of myeloablative therapy followed by autologous... 
MEDICINE, GENERAL & INTERNAL | END-POINT | AUTOIMMUNE-DISEASES | DOSE IMMUNOSUPPRESSIVE THERAPY | CLINICAL-TRIALS | HEART-FAILURE | DOUBLE-BLIND | LUNG-DISEASE | MARROW-TRANSPLANTATION | PULSE CYCLOPHOSPHAMIDE | SEVERE SYSTEMIC-SCLEROSIS | Follow-Up Studies | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Kaplan-Meier Estimate | Male | Transplantation, Autologous | Hematopoietic Stem Cell Transplantation - mortality | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Infection - etiology | Young Adult | Disease-Free Survival | Scleroderma, Systemic - therapy | Scleroderma, Systemic - mortality | Adolescent | Hematopoietic Stem Cell Transplantation - adverse effects | Intention to Treat Analysis | Adult | Female | Immunosuppressive Agents - adverse effects | Aged | Transplantation Conditioning | Scleroderma, Systemic - drug therapy | Treatment outcome | Care and treatment | Systemic scleroderma | Analysis | Patient outcomes | Scleroderma (Disease) | Stem cells | Transplantation | CD34 antigen | Medical research | Autografts | Kidneys | Transplants & implants | Toxicity | Hypersensitivity | Stem cell transplantation | Sclerosis | Immunosuppressive agents | Hemopoiesis | Cyclophosphamide | Immunosuppression | Infectious diseases | Systemic sclerosis | Renal failure | Skin | Scleroderma | Heart diseases | Kidney transplantation | Index Medicus | Abridged Index Medicus
Journal Article
Leukemia, ISSN 0887-6924, 08/2015, Volume 29, Issue 8, pp. 1754 - 1762
Clinical outcomes after primary graft failure (PGF) remain poor. Here we present a large retrospective analysis (n = 23 272) which investigates means to... 
RISK-FACTORS | MAJOR-HISTOCOMPATIBILITY-COMPLEX | ONCOLOGY | MATCHED UNRELATED DONORS | BONE-MARROW-TRANSPLANTATION | BLOOD STEM-CELL | ACUTE MYELOGENOUS LEUKEMIA | CLASS-I | SEVERE APLASTIC-ANEMIA | HEMATOLOGY | VERSUS-HOST-DISEASE | T-CELLS | Hematologic Neoplasms - therapy | Prognosis | Follow-Up Studies | Myeloablative Agonists - adverse effects | Hematologic Neoplasms - mortality | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Child, Preschool | Infant | Male | Transplantation, Homologous | Young Adult | Graft vs Host Disease - mortality | Hematopoietic Stem Cell Transplantation - adverse effects | Adult | Female | Transplantation Conditioning - adverse effects | Primary Graft Dysfunction - etiology | Retrospective Studies | Hematologic Neoplasms - complications | Child | Graft vs Host Disease - etiology | Infant, Newborn | Primary Graft Dysfunction - drug therapy | Graft Survival | Survival Rate | Graft vs Host Disease - drug therapy | Primary Graft Dysfunction - mortality | Adolescent | Aged | Neoplasm Staging | Care and treatment | Transplantation | Blood diseases | Patient outcomes | Stem cells | Index Medicus | leukemia | myelodysplastic syndrome | myeloproliferative disorders | Allogeneic hematopoietic cell transplantation | myeloablative | primary graft failure | Clinical Medicine | Medical and Health Sciences | Cancer and Oncology | Klinisk medicin | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Journal Article
Blood, ISSN 0006-4971, 12/2013, Volume 122, Issue 24, pp. 3863 - 3870
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2011, Volume 29, Issue 7, pp. 805 - 813
Journal Article